Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
Authors:
Open Access
- 1 October 2018
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 4 (9) , 860-862
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Steroid Withdrawal Effects Following Long-term Topical Corticosteroid UseDermatitis®, 2018
- Topical corticosteroid withdrawal in a pediatric patientJAAD Case Reports, 2017
- Topical corticosteroid addiction and withdrawal - An overview for GPs.2016
- A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatosesJournal of the American Academy of Dermatology, 2015
- Topical steroid addiction in atopic dermatitisDrug, Healthcare and Patient Safety, 2014
- Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndromeClinics in Dermatology, 2003
- Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammationClinical and Experimental Immunology, 2002
- Glucocorticoids inhibit the induction of nitric oxide synthase in macrophagesBiochemical and Biophysical Research Communications, 1990
- Cutaneous mast cell depletion results from topical corticosteroid usage.The Journal of Immunology, 1985